Skip to main content

Day: September 8, 2021

CVR Partners Announces Notice of Partial Redemption for its 9.250% Senior Secured Notes Due 2023

SUGAR LAND, Texas, Sept. 08, 2021 (GLOBE NEWSWIRE) — CVR Partners, LP (“CVR Partners”) (NYSE: UAN) today announced that CVR Partners and its indirect wholly owned subsidiary, CVR Nitrogen Finance Corporation (together with CVR Partners, the “Issuers”), delivered a notice of partial redemption for $15 million of the Issuers’ outstanding 9.250% Senior Secured Notes due 2023 (the “2023 Notes”) at a par redemption price, plus accrued and unpaid interest on the redeemed portion of the 2023 Notes, to be redeemed on September 23, 2021. As of June 30, 2021, there were outstanding $95 million aggregate principal amount of 2023 Notes. Wilmington Trust, National Association is the trustee for the 2023 Notes and is serving as the paying agent for the partial redemption. Forward-Looking Statements This news release contains forward-looking...

Continue reading

3D Systems to Drive Adoption of Additive Manufacturing in Production Environments with the Acquisition of Oqton

Oqton’s unique cloud-based, AI-enabled Manufacturing Operating System accelerates deployment and automation of digital manufacturing in production environments to improve efficiencies and reduce cost Oqton will operate as independent organization and solution platform company, ensuring data security and confidentiality for customers 3D Systems expands availability of 3DXpert®, 3D Sprint®, Geomagic®, and Additive Works’ Amphyon™ simulation software to entire additive industry The combination allows customers to accelerate adoption and productivity of additive manufacturing in existing production environments Companies to host a conference call and webcast tomorrow, September 9, 2021, at 8:00 a.m. Eastern Daylight TimeROCK HILL, S.C. and GHENT, Belgium, Sept. 08, 2021 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) today is pleased to...

Continue reading

ABM Industries Announces Results for Third Quarter Fiscal 2021

— Double-Digit Revenue Growth Reflected Y-o-Y Increases Across All Business Segments — — Continued Strong Operating Income From All Business Segments — — GAAP Results Include Reserve for Previously Reported Litigation Settlement — — Company Raises Adjusted EPS Guidance for Full Year Fiscal 2021 to Reflect Strong Year-to-Date Performance — — On August 25, 2021, Announced Definitive Agreement to Acquire Able Services — NEW YORK, Sept. 08, 2021 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced financial results for the third quarter of fiscal 2021. Scott Salmirs, President and Chief Executive Officer of ABM Industries commented, “ABM generated strong third quarter financial results, driven by continued broad-based demand for our services and efficient execution within an improving business...

Continue reading

Calavo Growers, Inc. Announces Third Quarter 2021 Financial Results

SANTA PAULA, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado-industry leader and provider of value-added fresh food, today reported its financial results for the third quarter ended July 31, 2021. Third Quarter HighlightsTotal revenue of $285.0 million, a 5% increase from the year-ago quarter. Fresh segment revenue was flat year-over-year, and Renaissance Food Group (“RFG”) and Foods segments revenues increased 14% and 12% year-over-year, respectively. Gross profit of $7.9 million, or 2.8% of revenue, compared to $30.8 million, or 11.4% of revenue, for the year-ago quarter. Net loss of $(13.0) million, or $(0.74) per diluted share, compared to net loss of $(15.6) million, or ($0.89) per diluted share, for the same period last year. Adjusted net loss was $(3.0) million, or $(0.17)...

Continue reading

Tactile Medical Announces Acquisition of AffloVest®

Further expands the Company’s position as a leader in treating patients with underserved chronic conditions in the home Transaction aligns with Tactile Medical’s growth & margin goals, including 20%+ revenue growth, gross margins above 70% and expanding adjusted EBITDA marginsMINNEAPOLIS, Sept. 08, 2021 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical” or the “Company”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home, today announced it has acquired the assets of the AffloVest respiratory therapy business from International Biophysics Corporation, a privately-held company which developed and manufactures AffloVest. AffloVest is a portable, wearable vest that treats patients with chronic respiratory conditions...

Continue reading

Intapp Announces Fourth Quarter and Full Fiscal Year 2021 Financial Results

Fourth quarter total revenue of $61.3 million, up 29% year-over-year Fourth quarter SaaS and support revenue of $39.4 million, up 26% year-over-year Cloud annual recurring revenue (ARR) of $109.7 million, up 48% year-over-yearPALO ALTO, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) — Intapp, Inc. (NASDAQ: INTA), a leading provider of industry-specific, cloud-based software solutions that enable connected professional and financial services firms, announced its financial results for the fiscal fourth quarter and full year ended June 30, 2021. “Intapp has created a unique cloud-based software platform designed specifically for the professional and financial services firms that facilitate the world’s economy,” said CEO John Hall. “In the fiscal fourth quarter of 2021, we delivered strong financial results driven by the continued adoption...

Continue reading

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2021 and Recent Developments

— Recorded First Quarter Revenue of $30.8 Million — — Achieved Fifth Consecutive Quarter of Operational Profitability — —  Signed $23 Million in New Business Orders and Ended the Quarter with a Backlog of $110 Million — — Phase 1 and Phase 2 Expansion Efforts Advancing as Planned — TUSTIN, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the first quarter of fiscal 2022, ended July 31, 2021. Highlights Since April 30, 2021 “We are pleased to announce another strong quarter.  During the first...

Continue reading

GameStop Reports Financial Results for Q2 2021

GRAPEVINE, Texas, Sept. 08, 2021 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today released financial results for the second quarter ended July 31, 2021. The Company’s condensed and consolidated financial statements, including GAAP and non-GAAP results, are below. The Company’s Form 10-Q and supplemental information can be found at http://investor.GameStop.com. SECOND QUARTER OVERVIEWGenerated net sales of $1.183 billion, compared to $942 million in the prior year’s second quarter.Ended the period with cash and restricted cash of $1.78 billion.Ended the period with no long-term debt, other than a $47.5 million low-interest loan associated with the French government’s pandemic response.Invested in long-term growth initiatives that include expanding the Company’s product catalog, enhancing...

Continue reading

Concrete Pumping Holdings Reports Third Quarter Fiscal Year 2021 Results

DENVER, Sept. 08, 2021 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”), a leading provider of concrete pumping and waste management services in the U.S. and U.K., reported financial results for the third quarter ended July 31, 2021. Third Quarter Fiscal Year 2021 Summary vs. Third Quarter of Fiscal Year 2020 (where applicable)Revenue increased 5% to $80.8 million compared to $77.1 million. Gross profit was $37.2 million compared to $37.8 million. Income from operations was $12.2 million compared to $10.8 million. Net income attributable to common shareholders improved to $4.1 million or $0.07 per diluted share, compared to a net loss attributable to common shareholders of $0.2 million or $0.00 per diluted share. Adjusted EBITDA1 was $28.4 million compared to $30.0 million, with adjusted...

Continue reading

Cullinan Oncology to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced its participation in the following upcoming investor conferences:Morgan Stanley 19th Annual Global Healthcare Conference taking place Thursday, September 9th through Wednesday, September 15thCullinan’s CEO, Owen Hughes, will participate in a virtual fireside chat on Monday, September 13th, at 12:30pm ET, and will provide a corporate update at 4:15pm ETH.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13th through Wednesday, September 15thCullinan’s Chief Development Officer of Biologics, Jennifer Michaelson, will participate in a panel discussion titled “Engineered Cytokines: The Next Big Wave in Immuno-oncology”, which will be broadcast to conference participants on Tuesday,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.